Your browser doesn't support javascript.
loading
Integrative Molecular Characterization of Malignant Pleural Mesothelioma.
Hmeljak, Julija; Sanchez-Vega, Francisco; Hoadley, Katherine A; Shih, Juliann; Stewart, Chip; Heiman, David; Tarpey, Patrick; Danilova, Ludmila; Drill, Esther; Gibb, Ewan A; Bowlby, Reanne; Kanchi, Rupa; Osmanbeyoglu, Hatice U; Sekido, Yoshitaka; Takeshita, Jumpei; Newton, Yulia; Graim, Kiley; Gupta, Manaswi; Gay, Carl M; Diao, Lixia; Gibbs, David L; Thorsson, Vesteinn; Iype, Lisa; Kantheti, Havish; Severson, David T; Ravegnini, Gloria; Desmeules, Patrice; Jungbluth, Achim A; Travis, William D; Dacic, Sanja; Chirieac, Lucian R; Galateau-Sallé, Françoise; Fujimoto, Junya; Husain, Aliya N; Silveira, Henrique C; Rusch, Valerie W; Rintoul, Robert C; Pass, Harvey; Kindler, Hedy; Zauderer, Marjorie G; Kwiatkowski, David J; Bueno, Raphael; Tsao, Anne S; Creaney, Jenette; Lichtenberg, Tara; Leraas, Kristen; Bowen, Jay; Felau, Ina; Zenklusen, Jean Claude; Akbani, Rehan.
Afiliação
  • Hmeljak J; Department of Pathology and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Sanchez-Vega F; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hoadley KA; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Shih J; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Stewart C; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Heiman D; Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Tarpey P; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.
  • Danilova L; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland.
  • Drill E; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gibb EA; GenomeDx Biosciences, Vancouver, British Columbia, Canada.
  • Bowlby R; Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.
  • Kanchi R; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Osmanbeyoglu HU; Computational Systems Biology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Sekido Y; Division of Cancer Biology, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
  • Takeshita J; Genome Science Division, The University of Tokyo, Tokyo, Japan.
  • Newton Y; Department of Biomolecular Engineering and Center for Biomolecular Science and Engineering, University of California, Santa Cruz, Santa Cruz, California.
  • Graim K; Department of Biomolecular Engineering and Center for Biomolecular Science and Engineering, University of California, Santa Cruz, Santa Cruz, California.
  • Gupta M; The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.
  • Gay CM; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Diao L; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gibbs DL; Institute for Systems Biology, Seattle, Washington.
  • Thorsson V; Institute for Systems Biology, Seattle, Washington.
  • Iype L; Institute for Systems Biology, Seattle, Washington.
  • Kantheti H; The University of Texas at Dallas, Richardson, Texas.
  • Severson DT; Division of Thoracic Surgery, The Lung Center and International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts.
  • Ravegnini G; Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
  • Desmeules P; Department of Pathology, Quebec Heart and Lung Institute, Quebec, Canada.
  • Jungbluth AA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Travis WD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Dacic S; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
  • Chirieac LR; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Galateau-Sallé F; MESOPATH. Cancer Center Leon Berard, Lyon, France.
  • Fujimoto J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Husain AN; Department of Pathology, University of Chicago, Chicago, Illinois.
  • Silveira HC; Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil.
  • Rusch VW; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rintoul RC; Department of Oncology, University of Cambridge, Cambridge, UK.
  • Pass H; Department of Cardiothoracic Surgery, NYU Langone Medical Center, New York, New York.
  • Kindler H; Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois.
  • Zauderer MG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kwiatkowski DJ; Division of Pulmonary Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Bueno R; Division of Thoracic Surgery, The Lung Center and International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts.
  • Tsao AS; Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Creaney J; School of Medicine and Pharmacology, University of Western Australia, Nedlands, Australia.
  • Lichtenberg T; The Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
  • Leraas K; The Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
  • Bowen J; The Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
  • Felau I; National Cancer Institute, Bethesda, Maryland.
  • Zenklusen JC; National Cancer Institute, Bethesda, Maryland.
  • Akbani R; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Discov ; 8(12): 1548-1565, 2018 12.
Article em En | MEDLINE | ID: mdl-30322867
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Biomarcadores Tumorais / Neoplasias Pulmonares / Mesotelioma / Mutação Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Biomarcadores Tumorais / Neoplasias Pulmonares / Mesotelioma / Mutação Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Discov Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos